PAHC

PAHC

Phibro Animal Health Corporation Delivers Strong First Quarter Performance

Phibro Animal Health Corporation has announced its first quarter results for fiscal 2027, showcasing a solid start to the year with sales growing 6% to $386.8 million and adjusted EBITDA increasing 4% to $64.3 million. The company's two non-animal health segments, Performance Products and Mineral Nutrition,

PAHC

Phibro Animal Health Corporation Roars into Record-Breaking Year

In a spectacular display of growth and resilience, Phibro Animal Health Corporation has achieved record-breaking net sales of over $1.5 billion for fiscal year 2026. According to the company's Q4 2026 conference call transcript, this remarkable milestone marks a 7% increase in total sales compared to the